Islay Capital Management, LLC Fulgent Genetics, Inc. Transaction History

Islay Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$47.98 - $62.75 $57,815 - $75,613	-1,205 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$49.85 - $96.11 $13,060 - $25,180	-262 Reduced 17.86%	1,205 $75,000
Q4 2021 Feb 08, 2022	BUY	$77.3 - $105.0 $14,996 - $20,370	194 Added 15.24%	1,467 $148,000
Q3 2021 Oct 18, 2021	BUY	$74.87 - $110.87 $10,556 - $15,632	141 Added 12.46%	1,273 $115,000
Q2 2021 Aug 02, 2021	BUY	$66.8 - $100.45 $75,617 - $113,709	1,132 New	1,132 $104,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Islay Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Islay Capital Management, LLC with notifications on news.